Next-Generation Non-Hodgkin Lymphoma Care: Spotlight on Therapeutic Approaches Targeting Protein Degradation Pathways

Learn more about cereblon E3 ligase modulators (CELMoDs) in the treatment of patients with non-Hodgkin lymphoma through a downloadable resource, on-demand webcast, and podcast including the latest available data.

Share

Program Content

Activities

Discussion on CELMoDs in NHL
Next-Generation Non-Hodgkin Lymphoma Care: Spotlight on Therapeutic Approaches Targeting Protein Degradation Pathways
Video
Congratulations: You achieved a completion on 04/09/2022

Released: August 21, 2024

Expires: August 20, 2025

Activities

Podcast: CELMoDs in Lymphomas
CELMoDs: Spotlight on Therapeutic Approaches Targeting Protein Degradation Pathways
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: July 11, 2024

Expires: July 10, 2025

Activities

CELMoDs in NHL
Practical Considerations for CELMoDs in NHL
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: May 23, 2024

Expires: May 22, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb